Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Globus Medical Q2 Adj. EPS $0.86 Beats $0.76 Estimate, Sales $745.342M Beat $738.903M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:16pm
Globus Medical (NYSE:GMED) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.76 by 13.16 percent. This is a 14.67 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $745.342 million which beat the analyst consensus estimate of $738.903 million by 0.87 percent. This is a 18.37 percent increase over sales of $629.691 million the same period last year.

Posted In: GMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist